0 Comments
0 Shares
1466 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- "Asthma Segment Dominates the COPD and Asthma Devices Market"The Infinium Global Research analyzes the Asthma and COPD Devices Market over the period of 2022 to 2028. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global asthma and copd devices market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of asthma and...0 Comments 0 Shares 529 Views 0 Reviews
- Asthma and COPD Drugs Market 2024 by Business Overview, Growing Demand, Key Companies, Opportunity Assessment and Forecast 2033Asthma and Chronic Obstructive Pulmonary Disease (COPD) are chronic respiratory conditions that affect millions of people worldwide. Both diseases significantly impact the quality of life and pose substantial burdens on healthcare systems. The market for drugs that treat asthma and COPD is vast, driven by the rising prevalence of these conditions, advancements in treatment options, and an aging...0 Comments 0 Shares 360 Views 0 Reviews
- Asthma And COPD Drugs Market Analysis, Size, Share, and Forecast 2031The Asthma And COPD Drugs Market in 2023 is US$ 38.04 billion, and is expected to reach US$ 55.6 billion by 2031 at a CAGR of 4.90%. FutureWise Research published a report that analyzes Asthma And COPD Drugs Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the...0 Comments 0 Shares 828 Views 0 Reviews
- Asthma and COPD Drugs Market Projected to Grow at a Steady Pace During 2022-2028The Asthma and COPD Drugs Market is segmented by Drug Class Type (Combination Drugs, Bronchodilators, Inhaled Corticosteroids (ICS), Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics, Anti-Inflammatories, Others), by Application Type (Asthma and COPD), by Distribution Channel...0 Comments 0 Shares 1764 Views 0 Reviews
- Asthma And COPD Market Is Estimated To Witness High Growth Owing To Rising Incidence Of Asthma And COPD CasesAsthma and COPD are chronic lung diseases that cause obstruction of airflow in the lungs. Asthma is caused due to inflammation and narrowing of the airways leading to wheezing, chest tightness, shortness of breath etc. COPD mainly includes chronic bronchitis and emphysema causing damage to the lungs over a period of time due to exposure to noxious particles or gases. Products available in the...0 Comments 0 Shares 1187 Views 0 Reviews
- China Asthma and COPD Drugs Market Demand, Size, Share, Growth Opportunities, Market Potential, Segmentation, Trends & Global Industry Forecast to 2032The Asthma and COPD Drugs Market is a pivotal segment in the pharmaceutical industry, focusing on the development and distribution of medications to manage respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Asthma and COPD are chronic respiratory disorders characterized by inflammation and airflow obstruction, and this market plays a crucial role in...0 Comments 0 Shares 483 Views 0 Reviews
- Chronic Obstructive Pulmonary Disease (COPD) devicesMarket Trends, Revenue, Major Players, Share Analysis & Forecast Till 2032The Chronic Obstructive Pulmonary Disease (COPD) devices market is expected to see a steady increase in revenue from USD 8.3 billion in 2022 to USD 14.02 billion in 2032, with a Compound Annual Growth Rate (CAGR) of 6%. This growth is driven by several factors, including the increasing prevalence of COPD globally, a growing number of elderly people, and a rising demand for non-invasive devices....0 Comments 0 Shares 2070 Views 0 Reviews
- Chronic Obstructive Pulmonary Disease (COPD) Market Size And Forecast 2024-2032Chronic Obstructive Pulmonary Disease (COPD) Market Analysis The Global Chronic Obstructive Pulmonary Disease (COPD) Market was valued at US$ 13.25 billion in 2023. It is estimated that the market will be worth US$ 17.22 billion by 2032, with a projected compound annual growth rate (CAGR) of 2.96% from 2024 to 2032. Factors contributing to this growth include, increased use of cigarettes...0 Comments 0 Shares 236 Views 0 Reviews
- Chronic Obstructive Pulmonary Disease (COPD) Market Size And Forecast 2024-2032Chronic Obstructive Pulmonary Disease (COPD) Market Analysis The Global Chronic Obstructive Pulmonary Disease (COPD) Market was valued at US$ 13.25 billion in 2023. It is estimated that the market will be worth US$ 17.22 billion by 2032, with a projected compound annual growth rate (CAGR) of 2.96% from 2024 to 2032. Factors contributing to this growth include, increased use of cigarettes...0 Comments 0 Shares 269 Views 0 Reviews
- Pulmonary Drugs: Effective Medications for Treating Respiratory ConditionsThe lungs are one of the most important organs in our body, responsible for delivering oxygen to our organs and removing carbon dioxide. Various pulmonary or respiratory conditions can affect the normal functioning of the lungs. Pulmonary drugs help in treating many such lung diseases and improving the respiratory health. BronchodilatorsBronchodilators are one of the most widely used classes...0 Comments 0 Shares 1452 Views 0 Reviews
- Advances in Chronic Obstructive Pulmonary Disease TreatmentCOPD is a progressive lung disease that makes it hard to breathe. Over time, COPD gets worse and the lungs lose their ability to fully inflate and deflate properly. This damages the lungs and weakens the muscles that help with breathing. As COPD gets more severe, even minimal physical activity can become very tiring. There is no cure for COPD, but treatment can help manage symptoms, slow its...0 Comments 0 Shares 1120 Views 0 Reviews
- Bronchodilators: Current Scenario and Future OpportunitiesBronchodilators are a class of drugs that are used to treat constriction or narrowing of the airways in respiratory disorders like asthma and chronic obstructive pulmonary disease (COPD). They work by relaxing and dilating (widening) the bronchial tubes and air passages in the lungs allowing for easier breathing. There are primarily two major classes of it- short-acting and long-acting....0 Comments 0 Shares 371 Views 0 Reviews
More Results